Medivir AB (publ) MVR.F Stock
Medivir AB (publ) Price Chart
Medivir AB (publ) MVR.F Financial and Trading Overview
| Medivir AB (publ) stock price | 0.64 EUR |
| Previous Close | 0.62 EUR |
| Open | 0.59 EUR |
| Bid | 0 EUR x 70000 |
| Ask | 0 EUR x 70000 |
| Day's Range | 0.59 - 0.62 EUR |
| 52 Week Range | 0.58 - 0.89 EUR |
| Volume | 960 EUR |
| Avg. Volume | 16 EUR |
| Market Cap | 35.99M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
MVR.F Valuation Measures
| Enterprise Value | 34.25M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.3176711 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Medivir AB (publ) Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -8.73% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.89 EUR |
| 52 Week Low | 0.58 EUR |
| 50-Day Moving Average | 0.65 EUR |
| 200-Day Moving Average | 0.73 EUR |
MVR.F Share Statistics
| Avg. Volume (3 month) | 16 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 55.72M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -62900000 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 1.958 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Medivir AB (publ)
| Country | Germany |
| State | N/A |
| City | Huddinge |
| Address | Lunastigen 5 |
| ZIP | N/A |
| Phone | 46 8 54 68 31 00 |
| Website | https://www.medivir.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 9 |
Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It is also developing Remetinostat for treating MF cutaneous T-cell lymphoma and basal cell carcinoma, as well as squamous cell carcinoma. In addition, the company is developing MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors, as well as USP-1/TNG348, USP-7, and MBLI/MET-X, which completed preclinical trials for treating cancer and infection. Medivir AB (publ) was incorporated in 1987 and is based in Huddinge, Sweden.
Q&A For Medivir AB (publ) Stock
What is a current MVR.F stock price?
Medivir AB (publ) MVR.F stock price today per share is 0.64 EUR.
How to purchase Medivir AB (publ) stock?
You can buy MVR.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Medivir AB (publ)?
The stock symbol or ticker of Medivir AB (publ) is MVR.F.
Which industry does the Medivir AB (publ) company belong to?
The Medivir AB (publ) industry is Biotechnology.
How many shares does Medivir AB (publ) have in circulation?
The max supply of Medivir AB (publ) shares is 57.51M.
What is Medivir AB (publ) Price to Earnings Ratio (PE Ratio)?
Medivir AB (publ) PE Ratio is 0.00000000 now.
What was Medivir AB (publ) earnings per share over the trailing 12 months (TTM)?
Medivir AB (publ) EPS is 0 EUR over the trailing 12 months.
Which sector does the Medivir AB (publ) company belong to?
The Medivir AB (publ) sector is Healthcare.